fluorescein has been researched along with loteprednol etabonate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, B; Bartels, SP; Chodosh, J; De Paiva, CS; Holland, EJ; Maskin, SL; Micuda, T; Pflugfelder, SC; Proskin, HM; Vogel, R | 1 |
| Dana, R; Dohlman, T; Kheirkhah, A; Saboo, U; Yin, J | 1 |
2 trial(s) available for fluorescein and loteprednol etabonate
| Article | Year |
|---|---|
A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
Topics: Androstadienes; Anti-Allergic Agents; Cornea; Double-Blind Method; Female; Fluorescein; Humans; Keratoconjunctivitis Sicca; Loteprednol Etabonate; Male; Middle Aged; Ophthalmic Solutions; Pilot Projects; Safety; Staining and Labeling; Suspensions; Tears; Tonometry, Ocular; Visual Acuity | 2004 |
Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease.
Topics: Administration, Ophthalmic; Anti-Allergic Agents; Chronic Disease; Conjunctiva; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Fluorophotometry; Glucocorticoids; Graft vs Host Disease; Humans; Loteprednol Etabonate; Lubricant Eye Drops; Male; Middle Aged; Prospective Studies; Staining and Labeling; Surveys and Questionnaires; Tears; Treatment Outcome | 2018 |